Neoadjuvant chemoimmunotherapy for inoperable ovarian cancer
نویسندگان
چکیده
منابع مشابه
Neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
The historical standard treatment paradigm for advanced epithelial ovarian cancer is surgical staging followed by adjuvant platinum- and taxane-based chemotherapy. It is well established that patients gain a survival advantage when optimal surgical debulking is achieved; surgical intervention that leaves bulky disease does not confer the same advantage. Thus, when optimal cytoreductive surgery ...
متن کاملNeoadjuvant Chemotherapy in Ovarian Cancer
Objective: The primary objective of the study was to compare the efficacy and safety of adjuvant chemotherapy (ACT) with neoadjuvant chemotherapy (NACT) in patients with ovarian epithelial cancer (OEC). Place & Duration of Study: This Randomized Controlled Trial was conducted at Shaukat Khanum Memorial Cancer Hospital & Research Center, Lahore (Pakistan). Patients were enrolled and treated over...
متن کاملNeoadjuvant Chemotherapy Creates Surgery Opportunities For Inoperable Locally Advanced Breast Cancer
Neoadjuvant chemotherapy (NAC), the systematic chemotherapy given to patients with locally advanced and inoperable breast caner, has been proven to be of great clinical values. Many scientific reports confirmed NAC could effectively eliminate sub-clinical disseminated lesions of tumor, and improve long-term and disease-free survival rate of patients with locally advanced breast cancer (LABC); h...
متن کاملNew drug in neoadjuvant chemoradiation for rectal cancer
Background: In recent years, neoadjuvant chemoradiation and subsequent surgical resection with total mesorectal excision has been shown to increase local control with decreased toxicity. Neoadjuvant chemoradiotherapy is the standard treatment for locally advanced rectal cancer. In this study we evaluated the efficacy a cox-2 inhibitor on pathologic response, sphincter preservation and acute tox...
متن کاملChemoimmunotherapy as a Novel Cancer Therapy
Over the past decade, it was widely accepted that some chemotherapeutic drugs can be combined with immunotherapeutic drugs in treatment of cancer. Chemotherapeutic drugs can induce apoptosis in the tumor cell and at the same time stimulate the immune response. Several reports support the use immunomodulators in treatment of cancers through regulating the immune response and boosting the micro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kazan medical journal
سال: 2018
ISSN: 2587-9359,0368-4814
DOI: 10.17816/kmj2018-010